From: Optimal INR level for warfarin therapy after mechanical mitral valve replacement
Characteristics | (N = 200) |
---|---|
Age (years), mean ± SD (range) | 50.30 ± 10.90 (18–75) |
Female gender, n (%) | 116 (58%) |
Atrial fibrillation, n (%) | 147 (73.5%) |
Comorbidity, n (%) | |
-Diabetes mellitus | 17 (8.5%) |
-Hypertension | 53 (26.5%) |
-Chronic kidney disease | 13 (6.5%) |
-Dyslipidemia | 41 (20.5%) |
-Coronary artery disease | 21 (10.5%) |
Echocardiographic findings | |
-LVEF (%), mean ± SD | 63.20 ± 10.60 |
-LVEF < 40%, n (%) | 7 (3.5%) |
-LA volume index (ml/m2), mean ± SD | 115.79 ± 75.72 |
-LA diameter (mm), mean ± SD | 58.88 ± 10.82 |
-LA thrombus, n (%) | 5 (2.5%) |
Concomitant aspirin, n (%) | 7 (3.5%) |
Pathology of valve disease, n (%) | |
-Rheumatic | 141 (70.5%) |
-Ruptured chordae tendinae | 35 (17.5%) |
-Prolapsed | 22 (11%) |
-Others | 2 (1%) |
Mechanical valve, n (%) | |
-Bileaflet valve | 200 (100%) |
Concomitant AVR, n (%) | 27 (13.5%) |